A series of B-ring trifluoromethylated flavonoids derivatives were prepared and tested in vitro against human gastric adenocarcinoma cell line (SGC-7901). Among these derivatives, 5, 7- dipropoxy-2-(4′-trifluoromethylphenyl)-chromen-4-one 5c had the strongest activity against SGC-7901 cell.